COPD epidemic could overwhelm healthcare systems within two decades, study says

September 20, 2016, University of British Columbia
Credit: Flickr

Health authorities should brace themselves for an epidemic of chronic obstructive pulmonary disease (COPD) over the next two decades, despite a decline in smoking rates, according to a new study from the University of British Columbia.

COPD is a progressive lung disease associated with smoking, air pollution and age. To predict future rates of the disease, researchers conducted forecasting analyses, combining population statistics and health data for the province of B.C. They concluded that between 2010 and 2030, the number of COPD cases in the province will increase by more than 150 per cent—despite decreased rates of smoking. Among seniors over 75 years of age, rates of COPD will more than triple, increasing by 220 per cent. The staggering figures astonished even the researchers.

"Everyone who has seen the results has been surprised," said senior author Dr. Mohsen Sadatsafavi, assistant professor in the faculties of pharmaceutical sciences and medicine. "Many people think that COPD will soon be a problem of the past, because smoking is declining in the industrialized world. But aging is playing a much bigger role, and this is often ignored. We expect these B.C.-based predictions to be applicable to Canada and many other industrialized countries."

Lead author Amir Khakban, health economist in the faculty of at UBC and the Centre for Health Evaluation and Outcome Sciences, said age-adjusted COPD rates have remained constant as have declined. "This pattern, along with an aging population and a decrease in mortality rates, is responsible for the alarming growth in the burden of COPD," he said.

While other diseases of aging are expected to increase over the coming decades, the researchers say COPD will overtake them all. The associated health-care costs of caring for these patients will be significant. The study predicts that annual inpatient days related to COPD will grow by 185 per cent. It's a burden the health-care system is not equipped to deal with, said co-author Dr. Don Sin, professor in UBC department of medicine's division of respiratory medicine and head of respiratory medicine at St. Paul's Hospital.

"Our only hope of changing this trajectory is to find new therapeutic and biomarker solutions to prevent and treat COPD, and this can only happen through research and innovation," he said. "Our UBC team is poised to make these breakthroughs."

"The Projected Epidemic of COPD Hospitalizations Over the Next 15 Years: A Population Based Perspective" appears in the American Journal of Respiratory and Critical Care Medicine.

Background

Key findings

From 2010 to 2030 in British Columbia:

  • The total population growth rate will be less than 25 per cent, while the total number of diagnosed COPD patients will increase by 155 per cent.
  • The absolute number of COPD cases will increase by more than 150 per cent.
  • The greatest growth will be in those 75 years of age or older, where the absolute number will increase by 220 per cent.
  • The burden of inpatient care, measured as the total annual inpatient days, will show a growth rate of 185 per cent.

About COPD:

  • COPD is the leading cause of hospitalization in Canada, after heart disease.
  • In the U.S. it is expected to surpass heart disease within five years to become the leading cause of hospitalizations.
  • Cigarette smoking is the single most important modifiable risk factor for COPD.

Explore further: Lung disease costs set to rise to GBP2.5bn per year, experts project

More information: Amir Khakban et al. The Projected Epidemic of COPD Hospitalizations Over the Next 15 Years: A Population Based Perspective, American Journal of Respiratory and Critical Care Medicine (2016). DOI: 10.1164/rccm.201606-1162PP

Related Stories

Lung disease costs set to rise to GBP2.5bn per year, experts project

September 1, 2016
The cost of treating a smoking-related chronic lung disease will exceed more than £2.3 billion per year in England - and £200 million in Scotland - by 2030, research suggests.

Considerable health care system burden for undiagnosed COPD

August 15, 2016
(HealthDay)—The overall health system burden of exacerbations in patients with undiagnosed chronic obstructive pulmonary disease (COPD) is considerable, according to a study published in the Aug. 1 issue of the American ...

COPD deaths down for most Americans: CDC

September 8, 2016
(HealthDay)—Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows.

Study suggests physical activity reduces anxiety and depression in patients with COPD

September 5, 2016
A study presented today at this year's European Respiratory Society (ERS) International Congress in London shows that increased physical activity among patients with chronic obstructive pulmonary disease (COPD) reduces their ...

Mother's smoking may increase her children's risk of lung disease as adults

March 11, 2016
An Australian study that followed patients over five decades reveals that children of mothers who smoke have an increased likelihood of developing chronic obstructive pulmonary disease (COPD) in adulthood.

Exacerbations of COPD accelerate lung-function loss

May 17, 2016
Exacerbations of chronic obstructive pulmonary disease (COPD) accelerate the loss of lung function especially among patients with mild disease, according to researchers at National Jewish Health and other institutions. Barry ...

Recommended for you

Small-scale poultry farming could mean big problem in developing countries

December 16, 2018
Small-scale farming in developing countries provides those in rural communities with income and access to protein, but it may have a large impact on antibiotic resistance, according to a new University of Michigan study.

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.